期刊文献+

建立预测阴茎鳞状细胞癌区域淋巴结转移风险的列线图 被引量:3

Construction of a nomogram predicting the risk of regional lymph node metastases in penile squamous cell carcinoma
原文传递
导出
摘要 目的根据阴茎癌原发灶的病理指标,建立预测阴茎鳞状细胞癌区域淋巴结转移风险的列线图。方法收集1990—2005年73例阴茎鳞状细胞癌患者资料,患者均接受阴茎肿瘤切除和区域淋巴结清扫术。免疫组化法检测分子指标(p53、Ki67、E-cadherin和MMP-9)的表达水平。采用Logistic回归模型建立列线图。预测淋巴结转移的变量包括年龄、分期、分级、蛋白表达水平(p53、Ki67、E—cadherin和MMP-9)和脉管侵犯。其中年龄为连续变量,分期、分级、蛋白表达水平和脉管侵犯为分类变量。结果肿瘤分级、p53表达水平和脉管侵犯是预测区域淋巴结转移的独立预后因素(P〈0.05),回归系数分别为3.97、2.12和2.37,OR值分别为52.99、8.33和10.70。用于预测淋巴结转移风险的列线图显示出良好的一致系数(0.92)和良好的校准。结论基于阴茎鳞状细胞癌原发灶的病理特征,构建预测区域淋巴结转移风险的列线图,不仅有助于个体化的判断肿瘤转移的风险,并且有助于与患者的交流和治疗选择。 Objective To construct and evaluate a nomogram for predicting the risk of regional lymph node metastases according to pathological features of the primary penile squamous cell carcinoma. Methods The clinical and pathological data of 73 patients who had undergone partial/radical penectomy and ilio/inguinal lymphadenectomy for squamous cell carcinoma of the penis from 1990 to 2005 were retrospectively collected. The expressions of molecular markers (p53, Ki-67, E-cadherin and MMP-9) were determined by immunohistochemistry. A logistic regression model was used to construct the nomogram. Results Tumor grade, the expression level of p53 and lymphovascular invasion were independent prognostic factors of regional lymph node involvement(P^0.05). The nomo- gram predicting the risk of metastatic lymph node involvement showed a good concordance index (0.92) and good calibration. Conclusions Based on the pathological findings of primary tumor, a nomogram to predict the probability of regional lymph node involvement in penile squamous cell carcinoma patients is constructed. This statistical tool is not only helpful in judging individualizing tumor risk, but also in facilitating patient's communication in treatment options.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2010年第3期207-210,共4页 Chinese Journal of Urology
关键词 阴茎肿瘤 淋巴转移 生物学标记 列线图 Penile neoplasms Lymphatic metastasis Biological markers Nomograms
  • 相关文献

参考文献9

  • 1Lynch DF, Pettaway CA. Tumors of the penis//Walsh PC, Retik AB, Stamey TA, et al. Campbell urology. 8th ed. Philadelphia: Saunders, 2002:2945 -2982.
  • 2Zhu Y, Zhou XY, Yao XD, et al. The prognostic significance of p53, Ki-67, epithelial eadherin and matrix metalloproteinase 9 in penile squamous cell carcinoma treated with surgery. BJU Int, 2007, 100:204-208.
  • 3Fraley EE, Zhang G, Manivel C, et al. The role of ilioinguinal lymphadenectomy and significance of histological differentia tion in treatment of carcinoma of the penis. J Urol, 1989, 142: 1478-1482.
  • 4Horenblas S, van Tinteren H. Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol, 1994, 151: 1239-1243.
  • 5Ficarra V, Zattoni F, Cunico SC, et al. Lymphatic and vascular embolizations are independent predictive variables of ingui nal lymph node involvement in patients with squamous cell carcinoma of the penis: Gruppo Uro-Oncologico del Nord Est (Northeast Uro-Oncological Group) Penile Cancer data base data. Cancer, 2005, 103:2507-2516.
  • 6Solsona E, Iborra I, Rubio J, et ai. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol, 2001, 165: 1506-1509.
  • 7Solsona E, Algaba F, Horenblas S, et al. EAU Guidelines on Penile Cancer. Eur Urol, 2004, 46: 1-8.
  • 8Solsona E, forra I, Ricos JV, et al. Corpus cavernosum invasion and tumor grade in the prediction of lymph node condition in penile carcinoma. Eur Urol, 1992, 22: 115-118.
  • 9Shariat SF, Karakiewicz PI, Suardi N, et al. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res, 2008, 14: 4400-4407.

同被引文献47

  • 1戴波,叶定伟,姚旭东,张海梁,沈益君,朱耀,朱一平,孔蕴毅.阴茎鳞状细胞癌区域性淋巴结转移的预测因子[J].中华泌尿外科杂志,2006,27(3):200-203. 被引量:8
  • 2Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. 9 th ed. Lyon: IARC Scientific Publications, 2007: 216-212.
  • 3Waterhouse J, Muir CS, Shanmugaratnam K, et al. Cancer incidence in five continents. 4th ed. Lyon: IARC Scientific Poblications, 1982: 1-811.
  • 4Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oneol, 2004, 5 : 240-247.
  • 5Pizzocaro G, Algaba F, Horenblas S, et al. EAU penile cancer guidelines 2009. Eur Urol, 2010, 57: 1002-1012.
  • 6Pompeo AC, Abrams P. Penile cancer--update. Urology, 2010, 76(2 Suppl 1) : S1.
  • 7徐祗顺.阴茎癌诊断治疗指南//那彦群,孙光.中国泌尿外科疾病诊断治疗指南.北京:人民卫生出版社,2009:82-96.
  • 8Pettaway CA, Lynch Jr DF, Davis JW. Tumors of the Penis// Wein AJ. Campbell-Walsh urology. 9th ed: Saunders elsevier, 2007 : 301-302.
  • 9Graafland NM, van Boven HH, van Werkhoven E, et al. Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma. J Urol, 2010, 184: 1347-1353.
  • 10Pagliaro LC, Williams DL, Daliani D, et al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase Ⅱ study. J Clin Oncol, 2010, 28: 3851-3857.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部